GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00016662 | Colorectum | MSS | response to hypoxia | 75/3467 | 307/18723 | 5.56e-03 | 3.78e-02 | 75 |
GO:0050678 | Colorectum | MSS | regulation of epithelial cell proliferation | 90/3467 | 381/18723 | 6.92e-03 | 4.45e-02 | 90 |
GO:0031099 | Colorectum | MSS | regeneration | 51/3467 | 198/18723 | 6.99e-03 | 4.49e-02 | 51 |
GO:0048762 | Colorectum | MSS | mesenchymal cell differentiation | 59/3467 | 236/18723 | 7.79e-03 | 4.84e-02 | 59 |
GO:00510983 | Colorectum | MSI-H | regulation of binding | 54/1319 | 363/18723 | 1.38e-07 | 1.30e-05 | 54 |
GO:00341013 | Colorectum | MSI-H | erythrocyte homeostasis | 24/1319 | 129/18723 | 1.03e-05 | 4.79e-04 | 24 |
GO:00300993 | Colorectum | MSI-H | myeloid cell differentiation | 50/1319 | 381/18723 | 1.52e-05 | 6.62e-04 | 50 |
GO:00018893 | Colorectum | MSI-H | liver development | 25/1319 | 147/18723 | 3.36e-05 | 1.31e-03 | 25 |
GO:00022623 | Colorectum | MSI-H | myeloid cell homeostasis | 26/1319 | 157/18723 | 3.79e-05 | 1.43e-03 | 26 |
GO:00610083 | Colorectum | MSI-H | hepaticobiliary system development | 25/1319 | 150/18723 | 4.76e-05 | 1.69e-03 | 25 |
GO:00487323 | Colorectum | MSI-H | gland development | 53/1319 | 436/18723 | 7.08e-05 | 2.35e-03 | 53 |
GO:00433933 | Colorectum | MSI-H | regulation of protein binding | 29/1319 | 196/18723 | 1.15e-04 | 3.48e-03 | 29 |
GO:00302183 | Colorectum | MSI-H | erythrocyte differentiation | 20/1319 | 120/18723 | 2.62e-04 | 6.65e-03 | 20 |
GO:00973052 | Colorectum | MSI-H | response to alcohol | 33/1319 | 253/18723 | 4.53e-04 | 9.61e-03 | 33 |
GO:00488723 | Colorectum | MSI-H | homeostasis of number of cells | 34/1319 | 272/18723 | 8.10e-04 | 1.49e-02 | 34 |
GO:19016543 | Colorectum | MSI-H | response to ketone | 26/1319 | 194/18723 | 1.17e-03 | 1.92e-02 | 26 |
GO:00311002 | Colorectum | MSI-H | animal organ regeneration | 13/1319 | 76/18723 | 2.35e-03 | 3.12e-02 | 13 |
GO:00310991 | Colorectum | MSI-H | regeneration | 25/1319 | 198/18723 | 3.27e-03 | 3.99e-02 | 25 |
GO:00434343 | Colorectum | FAP | response to peptide hormone | 100/2622 | 414/18723 | 1.74e-08 | 1.84e-06 | 100 |
GO:00487324 | Colorectum | FAP | gland development | 103/2622 | 436/18723 | 3.61e-08 | 3.12e-06 | 103 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TGFBR3 | SNV | Missense_Mutation | novel | c.448N>A | p.Glu150Lys | p.E150K | Q03167 | protein_coding | tolerated(0.13) | benign(0.085) | TCGA-A8-A06Q-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TGFBR3 | SNV | Missense_Mutation | novel | c.1621N>C | p.Glu541Gln | p.E541Q | Q03167 | protein_coding | tolerated(0.13) | probably_damaging(0.971) | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
TGFBR3 | SNV | Missense_Mutation | rs776276219 | c.1100N>C | p.Val367Ala | p.V367A | Q03167 | protein_coding | tolerated(0.71) | benign(0.055) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TGFBR3 | SNV | Missense_Mutation | | c.2429N>A | p.Ser810Tyr | p.S810Y | Q03167 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-AO-A03V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | fluorouracil | SD |
TGFBR3 | SNV | Missense_Mutation | | c.293N>C | p.Lys98Thr | p.K98T | Q03167 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
TGFBR3 | SNV | Missense_Mutation | novel | c.67N>C | p.Glu23Gln | p.E23Q | Q03167 | protein_coding | tolerated(0.1) | benign(0.412) | TCGA-C8-A12P-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TGFBR3 | SNV | Missense_Mutation | | c.947T>C | p.Ile316Thr | p.I316T | Q03167 | protein_coding | tolerated(0.75) | benign(0.055) | TCGA-EW-A2FS-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | goserelin | SD |
TGFBR3 | insertion | Frame_Shift_Ins | novel | c.1618_1619insCCCTGCACAGTCCCCTTAGCCCCCAGCAGGGCAGCCAA | p.Tyr540SerfsTer51 | p.Y540Sfs*51 | Q03167 | protein_coding | | | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
TGFBR3 | insertion | Frame_Shift_Ins | novel | c.2012_2013insATTAGATTCAAATA | p.Lys672LeufsTer41 | p.K672Lfs*41 | Q03167 | protein_coding | | | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
TGFBR3 | SNV | Missense_Mutation | rs373781090 | c.2240C>T | p.Thr747Met | p.T747M | Q03167 | protein_coding | deleterious(0.03) | probably_damaging(0.944) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | CYTOKINES | | 16634800 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | DEXAMETHASONE | DEXAMETHASONE | 8143777 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | RANTES | | 14637022 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | BFGF | | 1556106 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | antidepressants | | 23092981 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | GM-CSF | REGRAMOSTIM | 12471017 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | TG-C | | |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | TGF-BETA 2 | | 1744125 |
7049 | TGFBR3 | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, DRUGGABLE GENOME | | RETINOIC ACID | | 8143777 |